- Report Code: 12173
- Available Format: PDF
- Pages: 369
- Report Description
- Table of Contents
- Market Segmentation
- Request Free Sample
Chapter 1. Research Background
1.1 Research Objectives
1.2 Market Definition
1.3 Analysis Period
1.4 Market Data Reporting Unit
1.4.1 Value
1.5 Market Size Breakdown by Segment
1.5.1 Market Segmentation by Product Type
1.5.2 Drugs Market Segmentation by Disorder Type
1.5.3 Drugs Market Segmentation by Distribution Channel
1.5.4 Market Segmentation by Region
1.6 Key Stakeholders
Chapter 2. Research Methodology
2.1 Secondary Research
2.1.1 Paid
2.1.2 Unpaid
2.1.3 P&S Intelligence Database
2.2 Primary Research
2.2.1 Breakdown of Primary Research, by Region
2.2.2 Breakdown of Primary Research, by Industry Participant
2.2.3 Breakdown of Primary Research, by Company Type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Notes and Caveats
Chapter 3. Executive Summary
Chapter 4. Voice of Industry Experts/KOLs
Chapter 5. Market Indicators
5.1 Prevalence of Mental Disorders
Chapter 6. Definition of Market Segments
6.1 By Product Type
6.1.1 Drugs
6.1.1.1 Antidepressants
6.1.1.1.1 SSRIs
6.1.1.1.2 SNRIs
6.1.1.1.3 TCAs
6.1.1.1.4 MAOIs
6.1.1.1.5 Others
6.1.1.2 Anticonvulsants
6.1.1.3 Atypical antipsychotics
6.1.1.4 Benzodiazepines
6.1.1.5 Beta-blockers
6.1.2 Devices
6.2 By Disorder Type
6.2.1 Major Depressive Disorder
6.2.2 OCD
6.2.3 Phobia
6.2.4 PTSD
6.2.5 Others
6.3 By Distribution Channel
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Channels
6.3.4 Direct Channels
Chapter 7. Industry Outlook
7.1 Market Dynamics
7.1.1 Trends
7.1.1.1 Increasing number of mergers and acquisitions
7.1.2 Drivers
7.1.2.1 Increasing aging population
7.1.2.2 Growing awareness about mental diseases and their treatment
7.1.2.3 Rising number of product approvals
7.1.2.4 Impact analysis of drivers on market forecast
7.1.3 Restraints
7.1.3.1 Side effects associated with usage of drugs and devices
7.1.3.2 Availability of complementary and alternative medicines
7.1.3.3 Impact analysis of restraints on market forecast
7.1.4 Opportunities
7.1.4.1 Emerging economies are key opportunity areas for market players
7.2 Impact of COVID-19
7.3 Porter’s Five Forces Analysis
7.3.1 Bargaining Power of Buyers
7.3.2 Bargaining Power of Suppliers
7.3.3 Intensity of Rivalry
7.3.4 Threat of New Entrants
7.3.5 Threat of Substitutes
Chapter 8. Global Market Size and Forecast
8.1 Overview
8.2 Market Revenue, by Product Type (2025–2030)
8.2.1 Drugs Market Revenue, by Type (2025–2030)
8.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
8.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
8.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
8.3 Market Revenue, by Region (2025–2030)
Chapter 9. North America Market Size and Forecast
9.1 Overview
9.2 Market Revenue, by Product Type (2025–2030)
9.2.1 Drugs Market Revenue, by Type (2025–2030)
9.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
9.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
9.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
9.3 Market Revenue, by Country (2025–2030)
Chapter 10. Europe Market Size and Forecast
10.1 Overview
10.2 Market Revenue, by Product Type (2025–2030)
10.2.1 Drugs Market Revenue, by Type (2025–2030)
10.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
10.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
10.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
10.3 Market Revenue, by Country (2025–2030)
Chapter 11. APAC Market Size and Forecast
11.1 Overview
11.2 Market Revenue, by Product Type (2025–2030)
11.2.1 Drugs Market Revenue, by Type (2025–2030)
11.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
11.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
11.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
11.3 Market Revenue, by Country (2025–2030)
Chapter 12. LATAM Market Size and Forecast
12.1 Overview
12.2 Market Revenue, by Product Type (2025–2030)
12.2.1 Drugs Market Revenue, by Type (2025–2030)
12.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
12.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
12.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
12.3 Market Revenue, by Country (2025–2030)
Chapter 13. MEA Market Size and Forecast
13.1 Overview
13.2 Market Revenue, by Product Type (2025–2030)
13.2.1 Drugs Market Revenue, by Type (2025–2030)
13.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
13.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
13.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
13.3 Market Revenue, by Country (2025–2030)
Chapter 14. U.S. Market Size and Forecast
14.1 Overview
14.2 Market Revenue, by Product Type (2025–2030)
14.2.1 Drugs Market Revenue, by Type (2025–2030)
14.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
14.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
14.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 15. Canada Market Size and Forecast
15.1 Overview
15.2 Market Revenue, by Product Type (2025–2030)
15.2.1 Drugs Market Revenue, by Type (2025–2030)
15.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
15.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
15.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 16. Germany Market Size and Forecast
16.1 Overview
16.2 Market Revenue, by Product Type (2025–2030)
16.2.1 Drugs Market Revenue, by Type (2025–2030)
16.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
16.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
16.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 17. France Market Size and Forecast
17.1 Overview
17.2 Market Revenue, by Product Type (2025–2030)
17.2.1 Drugs Market Revenue, by Type (2025–2030)
17.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
17.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
17.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 18. U.K. Market Size and Forecast
18.1 Overview
18.2 Market Revenue, by Product Type (2025–2030)
18.2.1 Drugs Market Revenue, by Type (2025–2030)
18.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
18.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
18.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 19. Italy Market Size and Forecast
19.1 Overview
19.2 Market Revenue, by Product Type (2025–2030)
19.2.1 Drugs Market Revenue, by Type (2025–2030)
19.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
19.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
19.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 20. Spain Market Size and Forecast
20.1 Overview
20.2 Market Revenue, by Product Type (2025–2030)
20.2.1 Drugs Market Revenue, by Type (2025–2030)
20.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
20.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
20.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 21. China Market Size and Forecast
21.1 Overview
21.2 Market Revenue, by Product Type (2025–2030)
21.2.1 Drugs Market Revenue, by Type (2025–2030)
21.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
21.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
21.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 22. Japan Market Size and Forecast
22.1 Overview
22.2 Market Revenue, by Product Type (2025–2030)
22.2.1 Drugs Market Revenue, by Type (2025–2030)
22.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
22.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
22.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 23. India Market Size and Forecast
23.1 Overview
23.2 Market Revenue, by Product Type (2025–2030)
23.2.1 Drugs Market Revenue, by Type (2025–2030)
23.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
23.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
23.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 24. Australia Market Size and Forecast
24.1 Overview
24.2 Market Revenue, by Product Type (2025–2030)
24.2.1 Drugs Market Revenue, by Type (2025–2030)
24.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
24.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
24.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 25. South Korea Market Size and Forecast
25.1 Overview
25.2 Market Revenue, by Product Type (2025–2030)
25.2.1 Drugs Market Revenue, by Type (2025–2030)
25.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
25.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
25.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 26. Brazil Market Size and Forecast
26.1 Overview
26.2 Market Revenue, by Product Type (2025–2030)
26.2.1 Drugs Market Revenue, by Type (2025–2030)
26.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
26.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
26.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 27. Mexico Market Size and Forecast
27.1 Overview
27.2 Market Revenue, by Product Type (2025–2030)
27.2.1 Drugs Market Revenue, by Type (2025–2030)
27.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
27.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
27.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 28. Saudi Arabia Market Size and Forecast
28.1 Overview
28.2 Market Revenue, by Product Type (2025–2030)
28.2.1 Drugs Market Revenue, by Type (2025–2030)
28.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
28.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
28.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 29. South Africa Market Size and Forecast
29.1 Overview
29.2 Market Revenue, by Product Type (2025–2030)
29.2.1 Drugs Market Revenue, by Type (2025–2030)
29.2.1.1 Antidepressants drugs market revenue, by type (2025–2030)
29.2.2 Drugs Market Revenue, by Disorder Type (2025–2030)
29.2.3 Drugs Market Revenue, by Distribution Channel (2025–2030)
Chapter 30. Competitive Landscape
30.1 List of Market Players and Their Offerings
30.2 Product Benchmarking
30.3 Recent Strategic Developments of Key Players
30.3.1 Product Launches and Approvals
30.3.2 Mergers and Acquisitions
30.3.3 Others
Chapter 31. Company Profiles
31.1 Novartis AG
31.1.1 Business Overview
31.1.2 Product and Service Offerings
31.1.3 Key Financial Summary
31.2 Pfizer Inc.
31.2.1 Business Overview
31.2.2 Product and Service Offerings
31.2.3 Key Financial Summary
31.3 Bristol-Myers Squibb Company
31.3.1 Business Overview
31.3.2 Product and Service Offerings
31.3.3 Key Financial Summary
31.4 Johnson & Johnson
31.4.1 Business Overview
31.4.2 Product and Service Offerings
31.4.3 Key Financial Summary
31.5 Merck & Co. Inc.
31.5.1 Business Overview
31.5.2 Product and Service Offerings
31.5.3 Key Financial Summary
31.6 AbbVie Inc.
31.6.1 Business Overview
31.6.2 Product and Service Offerings
31.6.3 Key Financial Summary
31.7 Eli Lilly and Company
31.7.1 Business Overview
31.7.2 Product and Service Offerings
31.7.3 Key Financial Summary
31.8 GlaxoSmithKline plc
31.8.1 Business Overview
31.8.2 Product and Service Offerings
31.8.3 Key Financial Summary
31.9 Sanofi
31.9.1 Business Overview
31.9.2 Product and Service Offerings
31.9.3 Key Financial Summary
31.10 H. Lundbeck A/S
31.10.1 Business Overview
31.10.2 Product and Service Offerings
31.10.2.1 Marketed products
31.10.2.2 Pipeline products
31.10.3 Key Financial Summary
31.11 Mylan N.V.
31.11.1 Business Overview
31.11.2 Product and Service Offerings
31.11.3 Key Financial Summary
31.12 Cipla Ltd.
31.12.1 Business Overview
31.12.2 Product and Service Offerings
31.12.3 Key Financial Summary
Get a bespoke market intelligence solution
Want a report tailored exactly to your business strategy?
Request CustomizationWant an insight-rich discussion with the report author?
Speak to Analyst
Our dedication to providing the most-accurate market information has earned us verification by Dun & Bradstreet (D&B). We strive for quality checking of the highest level to enable data-driven decision making for you
Our insights into the minutest levels of the markets, including the latest trends and competitive landscape, give you all the answers you need to take your business to new heights
With 24/7 research support, we ensure that the wheels of your business never stop turning. Don’t let time stand in your way. Get all your queries answered with a simple phone call or email, as and when required
We take a cautious approach to protecting your personal and confidential information. Trust is the strongest bond that connects us and our clients, and trust we build by complying with all international and domestic data protection and privacy laws